跳转至内容
Merck
CN
  • GCN2 inhibition sensitizes arginine-deprived hepatocellular carcinoma cells to senolytic treatment.

GCN2 inhibition sensitizes arginine-deprived hepatocellular carcinoma cells to senolytic treatment.

Cell metabolism (2022-07-16)
Rindert Missiaen, Nicole M Anderson, Laura C Kim, Bailey Nance, Michelle Burrows, Nicolas Skuli, Madeleine Carens, Romain Riscal, An Steensels, Fuming Li, M Celeste Simon
摘要

Hepatocellular carcinoma (HCC) is a typically fatal malignancy exhibiting genetic heterogeneity and limited therapy responses. We demonstrate here that HCCs consistently repress urea cycle gene expression and thereby become auxotrophic for exogenous arginine. Surprisingly, arginine import is uniquely dependent on the cationic amino acid transporter SLC7A1, whose inhibition slows HCC cell growth in vitro and in vivo. Moreover, arginine deprivation engages an integrated stress response that promotes HCC cell-cycle arrest and quiescence, dependent on the general control nonderepressible 2 (GCN2) kinase. Inhibiting GCN2 in arginine-deprived HCC cells promotes a senescent phenotype instead, rendering these cells vulnerable to senolytic compounds. Preclinical models confirm that combined dietary arginine deprivation, GCN2 inhibition, and senotherapy promote HCC cell apoptosis and tumor regression. These data suggest novel strategies to treat human liver cancers through targeting SLC7A1 and/or a combination of arginine restriction, inhibition of GCN2, and senolytic agents.

材料
货号
品牌
产品描述

Sigma-Aldrich
DAPI, for nucleic acid staining
登录查看公司和协议定价
货号包装规格是否有货价格数量
1 mg
有货
详情...
¥188.61
5 mg
有货
详情...
¥932.18
10 mg
有货
详情...
¥1,447.79
50 mg
有货
详情...
¥6,302.72
Sigma-Aldrich
抗-PCNA抗体,克隆PC10, clone PC10, from mouse
登录查看公司和协议定价
货号包装规格是否有货价格数量
200 μg
预计发货时间 2025年4月07日
详情...
针对您的靶标提供了无防腐剂重组抗体。试用 ZRB1442
¥4,239.58